Yuyu Pharma Inc (000225) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.021x

Based on the latest financial reports, Yuyu Pharma Inc (000225) has a cash flow conversion efficiency ratio of 0.021x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.95 Billion ≈ $2.00 Million USD) by net assets (₩142.56 Billion ≈ $96.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Yuyu Pharma Inc (000225) market capitalisation for the company's overall valuation and market capitalisation.

Yuyu Pharma Inc - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Yuyu Pharma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Yuyu Pharma Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yuyu Pharma Inc ranked by their cash flow conversion efficiency. Explore 000225 cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Medifron DBT Co. Ltd KQ:065650	-0.472x
DistIT AB (publ) ST:DIST	-0.109x
Physitrack PLC ST:PTRK	0.060x
GUILD ESPORTS PLC LS-001 F:GU0	N/A
Mixed Martial Arts Group Limited NYSE MKT:MMA	9.175x
Ugint Co Ltd KQ:195990	-0.098x
Samil Co.Ltd KQ:032280	0.015x
Sunlands Technology Group NYSE:STG	0.151x

Annual Cash Flow Conversion Efficiency for Yuyu Pharma Inc (2014–2025)

The table below shows the annual cash flow conversion efficiency of Yuyu Pharma Inc from 2014 to 2025. View Yuyu Pharma Inc (000225) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩140.54 Billion ≈ $95.24 Million	₩15.88 Billion ≈ $10.76 Million	0.113x	-38.84%
2024-12-31	₩135.06 Billion ≈ $91.53 Million	₩24.95 Billion ≈ $16.91 Million	0.185x	+5182.83%
2023-12-31	₩120.36 Billion ≈ $81.56 Million	₩420.86 Million ≈ $285.21K	0.003x	+106.93%
2022-12-31	₩123.37 Billion ≈ $83.61 Million	₩-6.23 Billion ≈ $-4.22 Million	-0.050x	-244.10%
2021-12-31	₩128.69 Billion ≈ $87.21 Million	₩4.51 Billion ≈ $3.06 Million	0.035x	+253.64%
2020-12-31	₩117.04 Billion ≈ $79.31 Million	₩-2.67 Billion ≈ $-1.81 Million	-0.023x	-115.66%
2019-12-31	₩90.54 Billion ≈ $61.36 Million	₩13.19 Billion ≈ $8.94 Million	0.146x	+107.05%
2018-12-31	₩86.87 Billion ≈ $58.87 Million	₩6.11 Billion ≈ $4.14 Million	0.070x	+937.85%
2017-12-31	₩82.83 Billion ≈ $56.14 Million	₩561.35 Million ≈ $380.42K	0.007x	-94.60%
2016-12-31	₩78.29 Billion ≈ $53.06 Million	₩9.82 Billion ≈ $6.65 Million	0.125x	+179.12%
2015-12-31	₩73.73 Billion ≈ $49.97 Million	₩-11.68 Billion ≈ $-7.92 Million	-0.158x	-930.90%
2014-12-31	₩71.49 Billion ≈ $48.45 Million	₩1.36 Billion ≈ $923.95K	0.019x	--

About Yuyu Pharma Inc

KO:000225 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$14.43 Million

₩21.30 Billion KRW

Market Cap Rank

#26186 Global

#1973 in Korea

Share Price

₩3635.00

Change (1 day)

-1.76%

52-Week Range

₩3375.00 - ₩5250.00

All Time High

₩25149.31